GlobeNewswire Press

  1. Generex Publishes Results From Pre-Clinical Studies On Immunotherapeutic Vaccine For HPV-Induced Cervical Cancer 7/23/2009
    Generex Biotechnology Corporation announced today publication of studies demonstrating the anti-cancer activity of a novel Ii-Key/HPV immunotherapeutic vaccine.
  2. Myriad Pharmaceuticals, Inc. Established As An Independent Pharmaceutical Development Company 7/2/2009
    Myriad Pharmaceuticals, Inc. (MPI) today announced that it has completed its previously announced spin-off from Myriad Genetics, Inc. as of 11:59 p.m. last evening.